Method for producing a synthetic antigen presenting transformed Drosophila cell
US6362001B1 · kind B1 · utility
14Cited by
4References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 16, 1998 |
| Grant date | Mar 26, 2002 |
| Priority date | — |
| Expiry date | Mar 16, 2018 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/827
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Materials and methods of activating T lymphocytes with specificity for particular antigenic peptides are described, as well as the use of activated T lymphocytes in vitro for the treatment of a variety of disease conditions. In particular, a method for producing a synthetic antigen presenting drosophila cell line for activating T lymphocytes to a specific peptide is described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.